-
The antibody-drug conjugate trastuzumab deruxtecan delays cancer growth for women with hormone receptor-positive (HR+)...
-
According to a new study presented at the 2024 ASCO Annual Meeting, adding the antibody-drug conjugate...
-
For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment...
-
Results from a new study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual...
-
A recent study by researchers at University of Limerick (UL) has identified high rates of anaemia...
-
Artificial intelligence (AI) is here to stay and is well on its way to transforming how...
-
The Irish Society of Rheumatology (ISR) 2024 Spring Meeting was “a great success with a wide...
-
Interferon seems to raise migraine risk in people with MS, while rituximab may lower it. A...
-
The American Headache Society recently issued a position statement update on the use of migraine prevention...
-
Prof Geoffrey Rose, Consultant Orbital, Lacrimal and Plastic Reconstructive Surgeon...
-
Therapeutic cancer vaccines are being heralded as the next big thing in the rapidly advancing field...
-
Patients with advanced kidney disease had nearly eightfold higher rates of anaemia compared with those...
Related Sites
Related Sites
Sign In
NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Register